Novel Treatment Paradigms: Primary IgA Nephropathy

Selvaskandan, Haresh; Barratt, Jonathan; Cheung, Chee Kay

doi:10.1016/j.ekir.2023.11.026

Kidney International Reports

2024

DOI: 10.1016/j.ekir.2023.11.026

|View full text |Cite

Novel Treatment Paradigms: Primary IgA Nephropathy

Haresh Selvaskandan,

Jonathan Barratt,

Chee Kay Cheung

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 9 publications

References 71 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis

Vivarelli,

Samuel,

Coppo

et al. 2024

Pediatr Nephrol

View full text Add to dashboard Cite

IgA nephropathy and IgA vasculitis with nephritis, albeit rare, represent two relatively frequent glomerular conditions in childhood. Compared to adults, pediatric IgA nephropathy has a more acute presentation, most frequently with synpharyngitic macrohematuria and histologically with more intense inflammation and less intense chronic damage. Management of these conditions is controversial and supported by little high-quality evidence. The paucity of evidence is due to the disease heterogeneity, its inter-ethnic variability, and the difficulty of extrapolating data from adult studies due to the peculiarities of the condition in children. IgA vasculitis with nephritis is a kidney manifestation of a systemic disorder, typical of the pediatric age, in which both the diagnosis of kidney involvement and its management are poorly defined, and an interdisciplinary approach is crucial. Both conditions can have a profound and long-lasting impact on kidney function and the global health of affected children. The International Pediatric Nephrology Association has therefore convened a diverse international group of experts from different disciplines to provide guidance on the recommended management of these conditions in children and to establish common definitions and define priorities for future high-quality, evidence-based collaborative studies for the benefit of children.

show abstract

IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis

Vivarelli,

Samuel,

Coppo

et al. 2024

Pediatr Nephrol

View full text Add to dashboard Cite

show abstract

Urinary Soluble CD163: A Novel Biomarker Suggests Who Should Receive Glucocorticoids in IgA Nephropathy

Li,

Thanabalasingam

2024

Kidney International Reports

View full text Add to dashboard Cite

Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?

Selvaskandan,

Barratt

2024

Kidney International

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Novel Treatment Paradigms: Primary IgA Nephropathy

Cited by 9 publications

References 71 publications

IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis

IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis

Urinary Soluble CD163: A Novel Biomarker Suggests Who Should Receive Glucocorticoids in IgA Nephropathy

Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?

Contact Info

Product

Resources

About